Updates are available Correction dated 2026-03-02
Click to view Correction: https://doi.org/10.1038/s41408-026-01454-6
-
Authors
Salter, Brittany https://orcid.org/0000-0002-4253-2924
Garcia-Horton, Alejandro https://orcid.org/0000-0003-0579-6709
Walker, Irwin https://orcid.org/0000-0003-0430-3837
Leber, Brian
Lepic, Kylie
Mian, Hira https://orcid.org/0000-0003-1584-1067
Gayowsky, Anastasia
Pond, Gregory R.
Seow, Hsien
Berg, Tobias
- License Information
-
More Information
Article History
Received: 18 July 2025
Revised: 26 September 2025
Accepted: 11 November 2025
First Online: 23 November 2025
Change Date: 27 February 2026
Change Type: Update
Change Details: The original online version of this article was revised: In this article, the wrong version of Table 1 has been used. This has been corrected.
Change Date: 2 March 2026
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41408-026-01454-6
Competing interests
: TB received research funding from Imago Biosciences (a subsidiary of Merck) and honoraria from AVIR Pharma, Jazz Pharmaceuticals, Bristol Myers Squibb, and Riemser Pharma GmbH, as well as travel funding from Incyte, Abbvie, Astellas, Alexion, and Celgene. There are no other relevant disclosures for this study for the remaining authors of this study.
